View Older Stories View More Recent Stories

Dec 17, 2020 10:00AM Octave Bioscience Secures $32 Million Series B Financing
Dec 17, 2020 08:00AM Global Genes, Leaders in Life Sciences and Pharma, and Informa’s Biotech Showcase™ Partner to Connect Rare Disease Advocates, Investors and Companies at RARE Beyond the Square
Dec 10, 2020 08:10AM Aytu BioScience (AYTU) Announces Merger Agreement with Neos Therapeutics
Dec 10, 2020 08:00AM Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company
Dec 10, 2020 06:01AM Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company
Dec 9, 2020 08:00AM Deerfield Announces 2021 Cure Diversity, Innovation and Management Initiatives
Dec 8, 2020 04:00PM Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
Dec 8, 2020 08:00AM Vatica Health Appoints Experienced Executive Shannon Delage to its Board of Directors
Nov 23, 2020 07:43PM Lumos Pharma to Participate in December Investor Conferences
Nov 23, 2020 07:42PM Lumos Pharma to Participate in December Investor Conferences
Nov 19, 2020 08:30AM Syngene and Deerfield Discovery and Development (3DC) sign 5-year strategic collaboration
Nov 16, 2020 04:19PM Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
Nov 16, 2020 07:30AM Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results
Nov 12, 2020 09:00AM Springtide Announces $18.1M in Funding to Accelerate Centers for Autism Care
Nov 12, 2020 08:00AM Bridge Medicines Announces Additional Funding of $10 Million from Inside Investors
Nov 10, 2020 04:01PM Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Nov 10, 2020 04:01PM Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Nov 10, 2020 08:00AM Boston Children’s Hospital and Deerfield Join Forces to Accelerate the Development of Novel Therapies to Patients
Nov 9, 2020 07:00AM Blade Therapeutics to Present at the 2020 Stifel Virtual Healthcare Conference
Oct 29, 2020 09:00AM Lumos Pharma to Participate in November Investor Conferences
Oct 29, 2020 09:00AM Lumos Pharma to Participate in November Investor Conferences
Oct 28, 2020 09:00AM Ready Launches Virtual Mental Health Services as Part of Unique At-Home Care Model
Oct 27, 2020 04:01PM Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
Oct 27, 2020 04:01PM Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
Oct 27, 2020 08:02AM Dracen Pharmaceutical's DRP-104 Granted U.S. FDA Fast Track Designation for the treatment of Non-Small Cell Lung Cancer
Oct 22, 2020 08:57AM Miami Residents to Receive COVID-19 Testing and Medical Care from On-Demand Healthcare Service Ready
Oct 21, 2020 09:30AM The New York Academy Of Medicine Welcomes New Board Chair Dr. Wayne Riley, President Of SUNY Downstate
Oct 21, 2020 08:05AM InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing
Oct 21, 2020 07:30AM Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development
Oct 6, 2020 04:40PM Nuo Therapeutics Announces Recapitalization and Exchange Agreement that Simplifies Capital Structure
Oct 6, 2020 08:00AM Curation Health Announces Series A Financing from Deerfield Management Company and WindRose Health Investors
Oct 1, 2020 09:00AM Olema Oncology Raises $85 Million in Series C Financing to Advance Clinical Development of OP-1250 in Breast Cancer
Sep 25, 2020 12:01PM Dracen Pharmaceuticals Announces the Initiation of First-in-human Study of DRP-104 in Adult Patients With Advanced Solid Tumors
Sep 22, 2020 02:56PM V-Wave Completes Financing of Up to $98M from Syndicate of Leading Global Healthcare Investors
Sep 21, 2020 08:08AM Bridge Medicines Adds Small Molecule Inhibitors of Activated Factor XII to Pipeline
Sep 16, 2020 10:02AM On-demand Healthcare Service, Ready, Raises $54 Million in Series C Financing
Sep 15, 2020 10:00AM Element Science Names Zubin J. Eapen, MD as Chief Medical Officer
Sep 14, 2020 07:00AM Blade Therapeutics Reaches Enrollment Goal for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients With COVID-19 Pneumonia
Sep 11, 2020 04:50PM Deerfield Healthcare Technology Acquisitions Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or about September 14, 2020
Sep 2, 2020 12:47PM BioNJ Announces Lineup for Virtual BioPartnering Conference
Aug 27, 2020 09:00AM Lumos Pharma to Participate in Upcoming Investor Conferences
Aug 27, 2020 09:00AM Lumos Pharma to Participate in Upcoming Investor Conferences
Aug 26, 2020 11:17AM Oxford Finance Provides Credit Facility to Brain Injury Rehab Provider ReMed Holdings, LLC
Aug 24, 2020 11:15AM Overdose Crisis Endures, Yet Few People Receive Existing Effective Treatment
Aug 14, 2020 04:40PM Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
Aug 13, 2020 04:01PM Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Aug 13, 2020 04:01PM Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Aug 12, 2020 07:00AM Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
View More Recent Stories View Older Stories